Loss per Share (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Earnings Per Share [Abstract] |
|
| Schedule of Antidilutive Securities Excluded from Diluted Loss per Share |
The following table provides a summary of instruments where underlying shares issuable upon exercise or conversion were excluded from the diluted loss per share calculation for the periods presented because their effect would be anti-dilutive. Additionally, the shares underlying the February 2025 Warrants, Funding Notes and Exchange Notes, each outstanding during the six months ended June 30, 2025, were excluded from diluted loss per share as their effect would be anti-dilutive.
|
|
|
|
|
|
|
|
|
|
|
2026 |
|
|
2025 |
|
Outstanding stock options |
|
|
667,413 |
|
|
|
49,210 |
|
Outstanding restricted stock units |
|
|
314,561 |
|
|
|
- |
|
Preferred stock |
|
|
1,126 |
|
|
|
1,126 |
|
Outstanding warrants (Note 12) |
|
|
1,817,714 |
|
|
|
155,345 |
|
Total |
|
|
2,800,814 |
|
|
|
205,681 |
|
|
| Schedule of Computation of Basic Net Loss per Common Share |
The following table sets forth the computation of basic net loss per common share for the periods indicated, in thousands except share and per share data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Basic net income (loss) per common share calculation: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ |
(9,006 |
) |
|
$ |
5,151 |
|
|
$ |
(15,952 |
) |
|
$ |
(12,250 |
) |
Income attributable to 2025 Series A Warrants |
|
— |
|
|
|
(1,665 |
) |
|
|
— |
|
|
|
— |
|
Income attributable to 2025 Series B Warrants |
|
— |
|
|
|
(2,295 |
) |
|
|
— |
|
|
|
— |
|
Net income (loss) attributable to common stockholders – basic |
|
(9,006 |
) |
|
|
1,191 |
|
|
|
(15,952 |
) |
|
|
(12,250 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock outstanding – basic |
|
6,898,804 |
|
|
|
1,935,554 |
|
|
|
6,773,125 |
|
|
|
976,885 |
|
Net income (loss) per share of common stock – basic |
$ |
(1.31 |
) |
|
$ |
0.62 |
|
|
$ |
(2.36 |
) |
|
$ |
(12.54 |
) |
|
| Schedule of Computation of Diluted Net Loss per Share of Common Share |
The following table sets forth the computation of diluted net loss per common share for the periods indicated, in thousands except share and per share data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Diluted net loss per common share calculation: |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ |
(9,006 |
) |
|
$ |
5,151 |
|
|
$ |
(15,952 |
) |
|
$ |
(12,250 |
) |
Income attributable to 2025 Series A Warrants |
|
— |
|
|
|
(1,665 |
) |
|
|
— |
|
|
|
— |
|
Income attributable to 2025 Series B Warrants |
|
— |
|
|
|
(2,295 |
) |
|
|
— |
|
|
|
— |
|
Net income (loss) attributable to common stockholders |
|
(9,006 |
) |
|
|
1,191 |
|
|
|
(15,952 |
) |
|
|
(12,250 |
) |
Earnings attributable to March 2025 Series A and Series B Warrants |
|
— |
|
|
|
3,959 |
|
|
|
— |
|
|
|
— |
|
Change in fair value of warrant liabilities |
|
— |
|
|
|
(6,512 |
) |
|
|
— |
|
|
|
— |
|
Net loss attributable to common stockholders – diluted |
$ |
(9,006 |
) |
|
$ |
(1,362 |
) |
|
$ |
(15,952 |
) |
|
$ |
(12,250 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding – diluted |
|
6,898,804 |
|
|
|
8,366,199 |
|
|
|
6,773,125 |
|
|
|
976,885 |
|
Net loss per share of common stock – diluted |
$ |
(1.31 |
) |
|
$ |
(0.16 |
) |
|
$ |
(2.36 |
) |
|
$ |
(12.54 |
) |
|